• roche logo

A New Era in Cervical Cancer Screening to Improve Women’s Health


In 2014, the U.S. FDA approved the cobas® HPV Test as a first-line primary screening test for cervical cancer. This means that the cobas® HPV Test can now be used to replace the Pap test, if the doctor chooses to do so for primary screening.

Tell your friends and loved ones about HPV cervical screening